ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Letter To the Editor: Screening Revisited

May 20, 1994

NCI Plans Contract To Study Cancer Research Manpower Needs; Epidemiologist State Their Case

October 7, 1977

Natcher Subcommittee Kills Recision, Save NCI $17 Million

May 2, 1980

NCI Eases Some Cooperative Group Concern; DeVita Considers Other CCOP- Research Base Funding Option

April 2, 1982

NCI Advisors Approve Research Network On Screening

August 6, 2010

In Brief: Survey Finds Americans Misinformed About Leading Cause Of Cancer Death

July 10, 1998